AstraZeneca share price jumps after blood clots from vaccine dismissed as ‘extremely rare’

0
1

ASTRAZENECA’S stock price has surged this morning following the announcement that blood clots from the drug are “extremely rare”.
Daily Express :: City and Business Feed

LEAVE A REPLY

Please enter your comment!
Please enter your name here